Holocene Advisors, LP Avrobio, Inc. Transaction History

Holocene Advisors, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$10.54 - $19.3 $12 Million - $22 Million	-1,141,717 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.79 - $17.1 $5.06 Million - $6.77 Million	396,000 Added 53.1%	1,141,717 $15.9 Million
Q3 2020 Nov 16, 2020	BUY	$12.99 - $19.41 $1.02 Million - $1.53 Million	78,653 Added 11.79%	745,717 $9.71 Million
Q2 2020 Aug 14, 2020	BUY	$12.19 - $22.96 $2.2 Million - $4.14 Million	180,526 Added 37.1%	667,064 $11.6 Million
Q1 2020 May 15, 2020	BUY	$10.08 - $27.21 $4.9 Million - $13.2 Million	486,538 New	486,538 $7.57 Million

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.